Skip to content
Research Article Open access CC BY 4.0

Ergot Alkaloids: A Review on Therapeutic Applications

Niti Sharma, Vinay K. Sharma, Hemanth Kumar Manikyam, Acharya Bal Krishna

European Journal of Medicinal Plants · pp. 1–17 · Published 21 Apr 2016

10.9734/EJMP/2016/25975

Abstract

Ergot of Rye is a plant disease caused by the fungus Claviceps purpurea which infects the grains of cereals and grasses but it is being used for ages for its medicinal properties. All the naturally obtained ergot alkaloids contain tetracyclic ergoline ring system, which makes them structurally similar with other neurotransmitters such as noradrenaline, dopamine or serotonin. Due to this structure homology these alkaloids can be used for the treatment of neuro related conditions like migraine, Parkinson’s disease etc. For hundreds of years, it has been used in obsctrics and gynecology as an uterotonics. Ergot drugs have important role in treating prolactinomas and type II Diabetes. Their role in cancer treatment has also been established. These drugs constitute an important group of compounds called “Smart drugs” used to improve cognitive function and memory and other age related brain disorders. Structural resemblance with various neurotransmitters allows them to interact with a number of receptors which makes them work on different target thus designing new ergot based drugs with receptor subtype selectivity will be more effective.

Ergot alkaloids smart drugs ureotonic type II diabetes migraine Parkinson’s disease cancer

Cited by 20

Biosynthesis and synthetic biology of psychoactive natural products

Cooper S. Jamieson, Joshua Misa, Yi Tang · Chemical Society Reviews · 2021

Molecular Mechanisms of Nicergoline from Ergot Fungus in Blocking Human 5-HT3A Receptor

Minsu Pyeon, Myungmi Moon, Jeongyeon Yun · Journal of Microbiology and Biotechnology · 2024

The C-8-S-isomers of ergot alkaloids — a review of biological and analytical aspects

Jensen E. Cherewyk, Barry R. Blakley, Ahmad N. Al-Dissi · Mycotoxin Research · 2023

An Alternative Method of Reversed-Phase HPLC for Identification and Quantitative Determination 0f Ergot Alkaloids

A. A. Volnin, N. S. Tsybulko, P. S. Savin · Pharmaceutical Chemistry Journal · 2024

A RETROSPECTIVE OF RESEARCH ON ERGOT ALKALOIDS

Evstratova K.D. · "Medical & pharmaceutical journal "Pulse" · 2022

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

20

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.